Investor FAQs
Stockholm, Sweden
The Company was formed in 2004 in order to develop and commercialize Nefecon.
The Company is incorporated in Stockholm, Sweden
Calliditas was first listed at Nasdaq Stockholm in 2018, and at Nasdaq US in 2020
The fiscal year ends Dec 31
The auditor is Ernst&Young AB
Read more on our Auditor page
Please see our financial reports section
Please see our SEC filing section
Please see the Executive Management section and Board of Directors section
Please contact :
Mikael Widell, Head of Communications
Email: mikael.widell@calliditas.com
Telephone: +46 703 11 99 60